OLVIMULOGENE NANIVACIREPVEC
UNII CF19SF72O5

Substance Identification & Data

This profile provides standardized clinical and technical data for Olvimulogene Nanivacirepvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CF19SF72O5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1473430-36-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
CF19SF72O5
CAS Registry Number
1473430-36-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
OLVIMULOGENE NANIVACIREPVEC
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11165
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
FG-145
Identifier assigned by the United States Adopted Names Council.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Olvimulogene Nanivacirepvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

OLVIMULOGENE NANIVACIREPVEC

Common Names & Synonyms

DNA (RECOMBINANT VACCINIA VIRUS STRAIN LIVP CLONE GL-ONC1)
DNA (SYNTHETIC VACCINIA VIRUS ONCOLYTIC-STRAIN GLV-1H68 (COMPLETE GENOME))
GLV-1H68
OLVIMULOGENE NANIVACIREPVEC [INN]
OLVIMULOGENE NANIVACIREPVEC [USAN]
OLVIMULOGENE NANIVACIREPVEC [WHO-DD]
RECOMBINANT REPLICATION-COMPETENT ONCOLYTIC VACCINIA VIRUS VACV (LIVP STRAIN) COMPRISING INSERTION OF THE RUC-GFP, BETA-GALACTOSIDASE (LACZ) AND BETA-BLUCURONIDASE (GUSA) REPORTER GENES INTO THE F14.5L, J2R (THYMIDINE KINASE) AND A56R (HEMAGGLUTININ) LOCI, RESPECTIVELY

Technical Codes

GL-ONC1